Difficult diagnosis in a 17-year-old patient: Type 1 diabetes? Type 2 diabetes? Or "double diabetes"?

被引:0
|
作者
Warncke, K. [1 ,2 ,3 ,4 ,5 ]
Engelsberger, I. [1 ,2 ]
机构
[1] StKM GmbH, Klinikum Schwabing, Klin & Poliklin Kinder & Jugendmed, Kinderklin Munchen Schwabing, Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar AoR, D-80804 Munich, Germany
[3] Helmholtz Zentrum Munchen, Inst Diabet Forsch, Neuherberg, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Forsch Grp Diabet, Neuherberg, Germany
[5] Forsch Grp Diabet eV, Neuherberg, Germany
关键词
type; 1; diabetes; 2; double diabetes; diabetes therapy; AUTOANTIBODIES; CHILDREN;
D O I
10.1055/s-0034-1369979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medical history and clinical findings: We report on a 17-year-old boy with elevated blood glucose levels, elevated liver enzymes and obesity (BMI 32.3 kg/m(2)). Clinical examination showed acanthosis nigricans and a vitiligo. The rest of the physical examination was without pathological findings. Investigations: The HbA(1c) value was 8.6 % (71 mmol/mol), and postprandial C-peptide showed a maximum level of 1.3 nmol/l. The type 1 diabetes-associated autoantibodies against protein tyrosine phosphatase IA-2 and zinc-transporter-8 were positive, while autoantibodies to glutamic acid decarboxylase and insulin were negative. There was no ketonuria. Ultrasound showed steatohepatitis. Treatment and course: Under therapy with metformin up to 2x1 g, blood glucose levels and liver enzymes normalized after a few weeks. After two months, the HbA1c value was 6.0 % (42.1 mmol/mol), and a weight loss of 5 kg was recorded. Conclusion: In obese adolescent patients with diabetes, a clear classification right from the beginning is not always possible. Characteristic findings of type 1 and type 2 diabetes may be present simultaneously. In the presented patient, monotherapy with metformin was sufficient in the first year. Close monitoring
引用
收藏
页码:1097 / 1099
页数:3
相关论文
共 50 条
  • [41] Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study
    Cengiz, Eda
    Cheng, Peiyao
    Ruedy, Katrina J.
    Kollman, Craig
    Tamborlane, William V.
    Klingensmith, Georgeanna J.
    Gal, Robin L.
    Silverstein, Janet
    Lee, Joyce
    Redondo, Maria J.
    Beck, Roy W.
    PEDIATRIC DIABETES, 2017, 18 (07) : 566 - 573
  • [42] Epidemiology of Type 1 Diabetes
    Maahs, David M.
    West, Nancy A.
    Lawrence, Jean M.
    Mayer-Davis, Elizabeth J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (03) : 481 - +
  • [43] Immunotherapy for type 1 diabetes
    Allen, L. A.
    Dayan, C. M.
    BRITISH MEDICAL BULLETIN, 2021, 140 (01) : 76 - 90
  • [44] Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma
    Coppieters, K. T.
    Wiberg, A.
    Tracy, S. M.
    von Herrath, M. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 168 (01): : 5 - 11
  • [45] Prevention of type 1 diabetes
    Thrower, S. L.
    Bingley, P. J.
    BRITISH MEDICAL BULLETIN, 2011, 99 (01) : 73 - 88
  • [46] Microbiome and type 1 diabetes
    Siljander, Heli
    Honkanen, Jarno
    Knip, Mikael
    EBIOMEDICINE, 2019, 46 : 512 - 521
  • [47] Autoantibodies in type 1 diabetes
    Schmidt, KD
    Valeri, C
    Leslie, RDG
    CLINICA CHIMICA ACTA, 2005, 354 (1-2) : 35 - 40
  • [48] Autoantibodies in Type 1 diabetes
    Heras, Panagiotis
    Mantzioros, Marios
    Mendrinos, Dimitrios
    Heras, Vasilios
    Hatzopoulos, Antonios
    Xourafas, Vasilios
    Kritikos, Konstantinos
    Karagiannis, Stefanos
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : E40 - E42
  • [49] Viruses in type 1 diabetes
    Hyoty, Heikki
    PEDIATRIC DIABETES, 2016, 17 : 56 - 64
  • [50] Syphilis iridocyclitis in a patient with type 1 diabetes
    Comassi, Mario
    Natali, Andrea
    Solini, Anna
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 641 - 644